Age, Biography and Wiki
Roozbeh Ghaffari was born on 1979 in American, is an American biomedical engineer and neuroscientist. Discover Roozbeh Ghaffari's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 45 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
45 years old |
| Zodiac Sign |
N/A |
| Born |
1979 |
| Birthday |
|
| Birthplace |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on .
He is a member of famous Engineer with the age 45 years old group.
Roozbeh Ghaffari Height, Weight & Measurements
At 45 years old, Roozbeh Ghaffari height not available right now. We will update Roozbeh Ghaffari's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Roozbeh Ghaffari Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Roozbeh Ghaffari worth at the age of 45 years old? Roozbeh Ghaffari’s income source is mostly from being a successful Engineer. He is from . We have estimated Roozbeh Ghaffari's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Engineer |
Roozbeh Ghaffari Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Roozbeh Ghaffari is a biomedical engineer and neuroscientist.
He is currently CEO and co-founder of Epicore Biosystems, research associate professor at Northwestern University's Biomedical Engineering Department, and Director of Translational Research in the Querrey Simpson Institute for Bioelectronics.
Ghaffari obtained BS and M.Eng degrees in electrical engineering and bioelectrical engineering, respectively, from the Massachusetts Institute of Technology in 2001 and 2003.
He then completed his PhD research and training at the Harvard–MIT Program in Health Sciences and Technology (HST) in 2008.
Ghaffari was advised by Professor Dennis Freeman at the MIT Research Laboratory of Electronics, where he conducted research in auditory neuroscience and cochlear mechanisms using microfabrication and microfluidic technologies.
Upon completion of his PhD degree, Ghaffari co-founded MC10 Inc in 2008 (acquired by Medidata in 2020), and served as MC10's Chief Technology Officer until 2017.
Ghaffari then joined Northwestern University faculty where he currently serves as research associate professor in the Department of Biomedical Engineering and is co-founder and CEO of Epicore Biosystems.
Ghaffari's research focus lies at the interface of bioelectronics and biology.
His research and commercial efforts have led to the development of novel classes of bioelectronic devices and microfluidic-based systems for commercial applications in sports performance, consumer health, and personalized care.
He has published over 90 academic papers and is inventor on over 50 issued patents.
In 2008, Ghaffari co-authored the business plan for Diagnostics For All, a non-profit health diagnostics organization spun out of Prof. George Whitesides Laboratory at Harvard University.
Diagnostics for All won the grand prizes of the MIT 100K and Harvard Business School Social Enterprise business plan contests in 2008.
Ghaffari then co-founded MC10 Inc and Epicore Biosystems with his advisor, Prof. John A. Rogers.
He currently serves as CEO of Epicore Biosystems.
He also serves on the Board of Advisors of Blendoor, the advisory board of the University of Vermont's Department of Biomedical Engineering, and on the editorial board of Digital Biomarkers Journal and Sensors.
M* obile World Congress Gold Prize Winner (2018)
